Log In
Print
BCIQ
Print
Print this Print this
 

SP-333

  Manage Alerts
Collapse Summary General Information
Company Synergy Pharmaceuticals Inc.
DescriptionSecond-generation guanylate cyclase C (GCC; GUCY2C) agonist
Molecular Target Guanylate cyclase C (GCC) (GUCY2C)
Mechanism of ActionGuanylate cyclase C agonist
Latest Stage of DevelopmentPhase I
IndicationInflammatory bowel disease (IBD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today